
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1699 | -10.7538451801 | 1.5799 | 1.6 | 1.36 | 878143 | 1.45571744 | CS |
4 | -0.52 | -26.9430051813 | 1.93 | 2.025 | 1.36 | 1251564 | 1.66341696 | CS |
12 | -1.8 | -56.0747663551 | 3.21 | 3.3 | 1.36 | 1287088 | 2.17185154 | CS |
26 | -1.39 | -49.6428571429 | 2.8 | 3.305 | 1.36 | 1611137 | 2.60345136 | CS |
52 | -0.94 | -40 | 2.35 | 3.45 | 1.36 | 1681156 | 2.53134551 | CS |
156 | -10.52 | -88.1810561609 | 11.93 | 12.8 | 1.36 | 1088970 | 3.47049762 | CS |
260 | -14.49 | -91.1320754717 | 15.9 | 24.47 | 1.36 | 986915 | 4.54707107 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관